BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND RET, RET51, 5979, P07949, ENSG00000165731, MTC1, MEN2A, RET-ELE1, HSCR1, MEN2B, CDHF12
132 results:

  • 1. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.
    Hasegawa N; Hayashi T; Niizuma H; Kikuta K; Imanishi J; Endo M; Ikeuchi H; Sasa K; Sano K; Hirabayashi K; Takagi T; Ishijima M; Kato S; Kohsaka S; Saito T; Suehara Y
    Clin Orthop Relat Res; 2024 Mar; 482(3):549-563. PubMed ID: 38014853
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Kinase fusion positive intra-osseous spindle cell tumors: A series of eight cases with review of the literature.
    Suurmeijer AJH; Xu B; Torrence D; Dickson BC; Antonescu CR
    Genes Chromosomes Cancer; 2024 Jan; 63(1):e23205. PubMed ID: 37782551
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Pediatric head and neck manifestations associated with multiple endocrine neoplasia syndromes.
    Jellins T; Hill M; Prager JD; Francom CR; Chan CM; Schneider KW; Sharma A; Herrmann BW
    Int J Pediatr Otorhinolaryngol; 2023 Oct; 173():111703. PubMed ID: 37604101
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Inflammatory myofibroblastic tumors: recent progress and future of targeted therapy.
    Nakano K
    Jpn J Clin Oncol; 2023 Oct; 53(10):885-892. PubMed ID: 37394916
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. ret-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung cancer Harboring a ret Fusion.
    Aldea M; Marinello A; Duruisseaux M; Zrafi W; Conci N; Massa G; Metro G; Monnet I; Gomez Iranzo P; Tabbo F; Bria E; Guisier F; Vasseur D; Lindsay CR; Ponce-Aix S; Cousin S; Citarella F; Fallet V; Minatta JN; Eisert A; de Saint Basile H; Audigier-Valette C; Mezquita L; Calles A; Mountzios G; Tagliamento M; Remon Masip J; Raimbourg J; Terrisse S; Russo A; Cortinovis D; Rochigneux P; Pinato DJ; Cortellini A; Leonce C; Gazzah A; Ghigna MR; Ferrara R; Dall'Olio FG; Passiglia F; Ludovini V; Barlesi F; Felip E; Planchard D; Besse B
    J Thorac Oncol; 2023 May; 18(5):576-586. PubMed ID: 36646211
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Rare duplication of the CDC73 gene and atypical hyperparathyroidism-jaw tumor syndrome: A case report and review of the literature.
    Garrigues G; Batisse-Lignier M; Uhrhammer N; Privat M; Ponelle-Chachuat F; Kelly A; Gay-Bellile M; Viala S; Bidet Y; Bignon YJ; Cavaillé M
    Mol Genet Genomic Med; 2023 May; 11(5):e2133. PubMed ID: 36639964
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. bone and soft tissue tumors: clinicoradiologic-pathologic molecular-genetic correlation of novel fusion spindled, targetable-ovoid, giant-cell-rich, and round cell sarcomas.
    Fanburg-Smith JC; Smith JD; Flemming DJ
    Skeletal Radiol; 2023 Mar; 52(3):517-540. PubMed ID: 36542130
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Receptor Tyrosine Kinase Inhibitors for the Treatment of Recurrent and Unresectable bone Sarcomas.
    Albarrán V; Villamayor ML; Chamorro J; Rosero DI; Pozas J; San Román M; Calvo JC; Pérez de Aguado P; Moreno J; Guerrero P; González C; García de Quevedo C; Álvarez-Ballesteros P; Vaz MÁ
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430263
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Thyroid carcinoma metastases to central nervous system and vertebrae.
    Kleinschmidt-DeMasters B; Marshall C
    Folia Neuropathol; 2022; 60(3):292-300. PubMed ID: 36382481
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Fracture Risk in Pediatric Patients With men2b.
    Li I; Hartley IR; Klubo-Gwiedzdzinska J; Reynolds JC; Thomas BJ; Hogan J; Enyew MM; Dombi E; Ling A; Akshintala S; Venzon DJ; Del Rivero J; Collins M; Glod JW
    J Clin Endocrinol Metab; 2022 Nov; 107(12):e4371-e4378. PubMed ID: 36056624
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A comparative study of the clinical characteristics of patients with medication-related osteonecrosis of the jaw and osteoporosis or malignancy.
    Feng Z; An J; He Y; Zhang Y
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Nov; 134(5):543-547. PubMed ID: 35668004
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Novel Therapeutics and Treatment Strategies for Medullary Thyroid cancer.
    Walgama E; Busaidy N; Zafereo M
    Endocrinol Metab Clin North Am; 2022 Jun; 51(2):379-389. PubMed ID: 35662447
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Role of Hemoglobin Content of reticulocyte to Evaluate Anemia in Patients with Malignancy.
    Singh G; Chaudhry S; Kumawat A; Kumar G; Singh R
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443540
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Preoperative serum calcitonin may improve initial surgery for medullary thyroid cancer in patients with indeterminate cytology.
    Jassal K; Ravintharan N; Prabhakaran S; Grodski S; Serpell JW; Lee JC
    ANZ J Surg; 2022 Jun; 92(6):1428-1433. PubMed ID: 35412008
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Extension of Prophylactic Surgery in Medullary Thyroid Carcinoma. Differences Between Sporadic and Hereditary Tumours According to Calcitonin Levels and Lymph Node Involvement.
    Juez LD; Mercader E; Amunategui I; Febrero B; Rodríguez JM; Gómez-Ramírez J;
    World J Surg; 2022 Apr; 46(4):820-828. PubMed ID: 35089388
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Regulation of reverse electron transfer at mitochondrial complex I by unconventional Notch action in cancer stem cells.
    Ojha R; Tantray I; Rimal S; Mitra S; Cheshier S; Lu B
    Dev Cell; 2022 Jan; 57(2):260-276.e9. PubMed ID: 35077680
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Gab2 deficiency prevents Flt3-ITD driven acute myeloid leukemia in vivo.
    Spohr C; Poggio T; Andrieux G; Schönberger K; Cabezas-Wallscheid N; Boerries M; Halbach S; Illert AL; Brummer T
    Leukemia; 2022 Apr; 36(4):970-982. PubMed ID: 34903841
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer.
    Matrone A; Prete A; Nervo A; Ragni A; Agate L; Molinaro E; Giani C; Valerio L; Minaldi E; Piovesan A; Elisei R
    J Endocrinol Invest; 2021 Oct; 44(10):2139-2151. PubMed ID: 33594641
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Late diagnosis of metastatic pheochromocytoma in multiple endocrine neoplasia 2B with rapid clinical decline.
    Jester G; Hassanein H; El-Far A
    BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33541961
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Real-World Efficacy and Safety of Cabozantinib and Vandetanib in Advanced Medullary Thyroid cancer.
    Koehler VF; Adam P; Frank-Raue K; Raue F; Berg E; Hoster E; Allelein S; Schott M; Kroiss M; Spitzweg C
    Thyroid; 2021 Mar; 31(3):459-469. PubMed ID: 32781914
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 7.